| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/28/2023 | NextCure, Inc. | NXTC | Grant | Employee Stock Option (Right to Buy) | 309k | $1.55 | $479k | | 02/28/2023 |
| 06/22/2022 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $1.82 | $72.8k | | 06/22/2022 |
| 01/31/2022 | NextCure, Inc. | NXTC | Grant | Employee Stock Option (Right to Buy) | 262.4k | $5.57 | $1.5M | | 01/31/2022 |
| 06/25/2021 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $4.00 | $160k | | 06/25/2021 |
| 03/15/2021 | NextCure, Inc. | NXTC | Grant | Employee Stock Option (Right to Buy) | 300k | $12.59 | $3.8M | | 03/15/2021 |
| 06/23/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $3.27 | $130.8k | | 06/23/2020 |
| 02/28/2020 | NextCure, Inc. | NXTC | Grant | Employee Stock Option (Right to Buy) | 225k | $41.76 | $9.4M | | 02/28/2020 |
| 01/25/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 5.4k | $3.23 | $17.5k | | 01/25/2020 |
| 01/25/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $3.23 | $64.6k | | 01/25/2020 |
| 10/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Options (right to buy) | 5.2k | $3.24 | $16.7k | | 10/25/2019 |
| 07/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 3.8k | $4.40 | $16.7k | | 07/25/2019 |
| 04/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 5.6k | $2.94 | $16.6k | | 04/25/2019 |
| 01/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 6.1k | $2.74 | $16.7k | | 01/25/2019 |
| 01/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $2.74 | $54.8k | | 01/25/2019 |
| 10/25/2018 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 3.8k | $4.36 | $16.7k | | 10/25/2018 |
| 07/25/2018 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 2.8k | $5.92 | $16.8k | | 07/25/2018 |
| 04/25/2018 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 2.7k | $6.43 | $17.1k | | 04/25/2018 |
| 10/25/2017 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (Rights to buy) | 4k | $4.68 | $18.7k | | 10/25/2017 |
| 07/25/2017 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 3.3k | $5.64 | $18.5k | | 07/25/2017 |
| 06/16/2017 | GENVEC INC | GNVC | Payment of Exercise | Common Stock | 1.2k | $7.19 | $8.5k | | 06/16/2017 |
| 06/16/2017 | GENVEC INC | GNVC | Disposition | Common Stock | 1.1k | $0.00 | $0 | | 06/16/2017 |
| 06/16/2017 | GENVEC INC | GNVC | Exercise | Stock Options (right to buy) | 2.2k | $3.80 | $8.6k | | 06/16/2017 |
| 04/25/2017 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 7.8k | $2.32 | $18.1k | | 04/25/2017 |
| 01/25/2017 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $2.01 | $40.2k | | 01/25/2017 |
| 01/25/2017 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 9.7k | $2.01 | $19.5k | | 01/25/2017 |
| 10/25/2016 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 9.7k | $1.64 | $15.8k | | 10/25/2016 |
| 07/25/2016 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 9.1k | $1.73 | $15.8k | | 07/25/2016 |
| 04/27/2016 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 7.7k | $2.05 | $15.7k | | 04/27/2016 |
| 02/16/2016 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $1.59 | $31.8k | | 02/16/2016 |
| 04/05/2011 | Acer Therapeutics Inc. | ACER | Grant | Stock Option (right to buy) | 10.5k | $1.78 | $18.7k | | 04/05/2011 |
| 04/05/2011 | Acer Therapeutics Inc. | ACER | Grant | Stock Option (right to buy) | 10k | $1.78 | $17.8k | | 04/05/2011 |